Host-Pathogen Interaction in Tuberculosis: Immune Evasion Strategies of Mycobacterium tuberculosis
Tuberculosis remains one of the deadliest infectious diseases worldwide. Mycobacterium tuberculosis, the bacterium that causes TB, interacts closely with the human immune system. This interaction determines whether the infection is controlled or progresses to active disease.
The bacterium enters the body through the lungs. Macrophages, the first line of defense, engulf the bacteria. However, Mycobacterium tuberculosis uses clever strategies to survive inside these immune cells.
Moreover, the bacterium prevents the fusion of phagosomes with lysosomes. This stops the normal killing process inside macrophages. As a result, it can survive and multiply within the host cells for long periods.
Furthermore, Mycobacterium tuberculosis inhibits the production of important inflammatory cytokines. It also modulates the host’s immune response to reduce its own detection. Consequently, the immune system fails to mount a strong attack against the pathogen.
In addition, the bacterium forms granulomas in the lungs. These structures help the bacteria hide from immune cells while allowing them to persist in a dormant state. Thus, the infection can remain latent for years before reactivating.
The pathogen also modifies its cell wall lipids to evade immune recognition. These changes make it difficult for T-cells to identify and destroy infected cells effectively.
However, the host immune system does not remain completely passive. It activates various defense mechanisms, including the production of nitric oxide and reactive oxygen species. Still, Mycobacterium tuberculosis has evolved multiple ways to counter these responses.
Overall, the success of Mycobacterium tuberculosis lies in its sophisticated immune evasion strategies. These mechanisms allow the bacterium to survive inside the host for extended periods and cause disease when conditions become favorable.
In conclusion, understanding these host-pathogen interactions is crucial. It helps researchers develop better vaccines, diagnostic tools, and more effective treatments against tuberculosis.
CMP Bio World 